Caplight Logo









Coherence Biotech Co. Ltd.

Coherence Biotech Co. Ltd.

Private
TaipeiHealthcare & Life Scienceshttps://coherencebio.com/

Last Round

Seed

Jan 1, 2023

Total Funding Raised

$190,600

Company Overview

Coherence Biotech Co. Ltd. is a biotechnology company that develops a modular, programmable benchtop automation platform for cell and organoid assays to accelerate AI-driven drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Hardware + Subscription, Government Contracts

AI Layer

Infrastructure

Keywords

antibody engineeringantibody drugsautoimmune disease therapyoncologylab automationclinical stage biopharmaAI drug discoverymonoclonal antibodiesdrug discoverybiopharma licensingdrug discovery infrastructureautomated assaysbenchtop automationCROCDMOCD47 SIRPα pathway

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coherence Biotech Co. Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Coherence Biotech Co. Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2023
GrantJun 30, 2022

Key People

Founding team and executive leadership

Cole Wu

Co-Founder & CEO

Founding Team

Daniel FROELIGER

Chief Technology Officer

Executive Team

Coherence Biotech Co. Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2023

    $160K round led by National Development Fund

  • Jun 30, 2022

    Received $31K from Taipei City Government.

Coherence Biotech Co. Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Coherence Biotech Co. Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coherence Biotech Co. Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTaipei
Employee Range5
Year Founded2020
Last FundingJan 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.